Please login to the form below
24
Revenue 2017Eylea
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Eylea was produced by Bayer.
Regeneron’s application for Eylea in retinopathy of prematurity accepted for FDA priority review
Notably, the time required to complete treatment administration per patient was considerably less for Eylea than for laser, the company reported. ... Regeneron and Bayer are collaborating on the global development of Eylea, with Regeneron maintaining
Roche announces two-year data confirming Vabysmo improves neovascular age-related macular degeneration
In the two studies, nAMD patients received Vabysmo at intervals of two, three or four months or Regeneron’s Eylea (aflibercept) given every two months. ... Optical Coherence Tomography (OTC) tests also showed that extending the dosing schedule for
Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
year. Bayer hasn’t reported its fourth-quarter results yet, but made $1.8bn from Eylea in other markets in the first nine months of the year. ... The company is also trumpeting Beovu’s less frequent dosing schedule compared to Eylea.
Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture
s Eylea (aflibercept), which together account for the lion’s share of the wet AMD market by value. ... Alteogen and Momenta/Mylan have versions of Eylea in development, while Coherus and Xbrane Pharma are among companies which are working on Lucentis
Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
Head-to-head trial with rival Eylea could boost sales. The FDA has approved Novartis’ new VEGF inhibitor Beovu as a new treatment option for patients with the wet form of ... That compares to four to eight week dosing with Eylea, and every month with
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Mednet Group
PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
